Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / XERS - Xeris Continues To Execute And Build Long-Term Value Potential

XERS - Xeris Continues To Execute And Build Long-Term Value Potential

Xeris Pharmaceuticals Inc.
  • Xeris recently updated on full-year 2021 sales, reporting that it had hit the upper end of guidance for Gvoke and Keveyis.
  • Recorlev was approved just before year-end 2021, and now Xeris gets to leverage its existing endocrinology sales force to start commercializing it.
  • Currently trading at less than 3x this year's expected sales, Xeris remains a core portfolio holding for me.

For further details see:

Xeris Continues To Execute And Build Long-Term Value Potential
Stock Information
Company Name: Xeris Pharmaceuticals Inc.
Stock Symbol: XERS
Market: NASDAQ
Menu
XERS XERS Quote XERS Short XERS News XERS Articles XERS Message Board
Get XERS Alerts

News, Short Squeeze, Breakout and More Instantly...